Hong Kong Baptist University Patent applications |
Patent application number | Title | Published |
20160074324 | SLOW AND CONTROLLED RELEASED LIPOSOMAL GEL COMPOSITION COMPRISING HYPOGLYCEMIC ACTIVE INGREDIENT AND METHOD OF PREPARING THEREOF - The present invention provides a slow and controlled released liposomal gel composition for subcutaneous administration comprises insulin or exenatide as active ingredient for reduction of blood sugar level and method of preparation thereof. Said controlled released composition has high bioavailability and is demonstrated to be able to sustain release therapeutically effective concentration of drug over a period of time and without rapid release of drug after initial administration. Method of preparing the controlled released composition of the present invention comprises the following steps: mixing insulin or exenatide, lipid and aqueous dispersion medium together; then mixing with poloxamer (e.g. F127 or P123) and/or gelatin and hyaluronic acid (HA) or the like gel solution so as to form a protective layer on surface of every lipid micro vesicles or nano-vesicles for use in intramuscular, abdominal and subcutaneous administration. A single administration of the present composition lasts 2 to 7 days to reduce side-effects, such as pain and irritation. | 03-17-2016 |
20150261936 | Method for Separating and Analyzing Overlapping Data Components with Variable Delays in Single Trials - The present invention relates to a method for separating and analyzing overlapping data components with variable delays in single trials. In particular, the present invention relates to a method for separating and analyzing overlapping data components consistently occur in multiple realizations but locked to different time markers with variable inter-marker delays using an extended residue iteration decomposition (RIDE) algorithm. The present invention has applications in separating and analyzing event-related brain potential (ERP) data derived from single-trial responses. | 09-17-2015 |
20150239763 | Biogenic Flocculant Composition To Enhance Flocculation And Dewaterability Of Chemically Enhanced Primary Treatment Sludge - The present invention discloses a composite biogenic flocculant for enhancing flocculation and dewaterability of chemically enhanced primary treatment (CEPT) sludge. The present invention also discloses method of conditioning CEPT sludge using the composite biogenic flocculant. | 08-27-2015 |
20150209376 | MELANOGENESIS EFFECT OF SAPONINS OF GYNOSTEMMA PENTAPHYLLUM - The present invention provides composition and method for inducing melanogenesis. The composition comprising an effective amount of saponins extracted from herbal plants. | 07-30-2015 |
20150196612 | Anti-enterovirus 71 steroidal saponins and their preparation - The present invention discloses a novel composition with anti-viral effects comprises extracts from | 07-16-2015 |
20150085817 | METHOD FOR ACHIEVING RENDEZVOUS FOR COGNITIVE RADIO NETWORKS - A method for achieving rendezvous in a multiple access network having two or more access channels includes the steps of generating channel access sequences in rounds for each user of the multiple access network, wherein each round includes at least one jump-pattern and at least one stay-pattern, performing the at least one jump-pattern alternated by the at least one stay-pattern in each round, and whereupon the at least one jump-pattern alternated by the stay-pattern in each round are performed, continuously generate at least one channel access sequence rounds and perform the jump-pattern of the channel access sequence rounds until a user in the network achieves rendezvous with its intended neighbour user or users. | 03-26-2015 |
20150079128 | CHINESE MEDICINAL FORMULATION FOR TREATING INFLAMMATORY BOWEL DISEASE AND THE PREPARATION THEREOF - This invention relates to a Chinese medicinal formulation for the treatment of inflammatory bowel diseases, and a method of preparation thereof. The formulation comprises herbal components selected from a group consisting of Radix Codonopsis (Dangshen), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Sclerotium Poriae Cocos (Fu Ling), Rhizoma Zingiberis Officinalis (Gan Jiang), Radix Paeoniae Alba (Bai Shao) and Rhizoma Coptidis (Huanglian). | 03-19-2015 |
20150011646 | USAGE OF GUTTIFERONE K, A NATURAL COMPOUND FROM GARCINIA YUNNANENSIS HU ON TREATING HIGH METASTATIC ESOPHAGEAL CANCER - This invention is related to compounds isolated from various | 01-08-2015 |
20140357299 | SYSTEM AND METHOD FOR PROVIDING PROXIMITY INFORMATION - A method for privacy-preserving proximity detection comprising a grid-and-hashing paradigm, an optimal grid overlay and multi-level grids, which increases the detection accuracy while saving the wireless bandwidth. Furthermore, the present invention also provided a client-side location update scheme and the server-side update handling procedure for continuous proximity detection. The present invention is efficient and scalable under various system parameters and user moving speeds, in mobile geo-social networks. | 12-04-2014 |
20140353522 | Apparatus and methodology for flow fluorescence microscopic imaging - The present invention is to provide a flow fluorescence microscopic imaging apparatus. More particularly, it relates to a fluorescence microscopic imaging apparatus which combines the fluorescence microscopy excited by light sheet and flow cytometry. The present invention provides a new methodology in the field of flow cytometry based on the flow fluorescence microscopic imaging device, which is able to solve the problem of small depth-of-field (DOF) and the motion blur when the flow objects are imaged. | 12-04-2014 |
20140348965 | USE OF A FLAVANOL GLYCOSIDE FOR SUPPRESSING ACTIVATION OF STELLATE CELLS - A method for suppressing activation of pancreatic stellate cells of a subject includes administering a composition comprising a therapeutically effective amount of Eruberin A. A method of preventing, alleviating or treating pancreatic tumors or pancreatic tumors related diseases includes administering a composition comprising a therapeutically effective amount of Eruberin A. The Eruberin A may be extracted from | 11-27-2014 |
20140242013 | HERBAL COMPOSITION FOR SKIN-WHITENING AND ANTI-SKIN-AGING, METHOD OF PREPARATION AND THE USE THEREOF - This invention provides a Chinese medicinal formula comprising Atractylodis Macrocephalae Rhizoma, Glycyrrhizae Radix et Rhizoma, Angelicae sinensis Radix, Paeoniae Radix Alba and Poria for skin care. It further relates to a method for preparing bioactive fraction of this formula and to the applications of the bioactive fraction in skin-whitening and anti-skin-aging. | 08-28-2014 |
20140235877 | COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF FOR TREATING CANCER - The present invention provides two compounds, namely Compound A and B, as the potential anticancer drug, and a composition comprising said Compound A and/or B for treating cancer or tumor related diseases. The present invention also relates to methods of preparing the compounds from a natural source and a composition comprising the compounds, and using the same for treating cancer or tumor related diseases. | 08-21-2014 |
20140213614 | Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation - The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to methods for labeling, imaging and detecting the beta-amyloid (Aβ) peptides, oligomers, and fibrils in vitro by using carbazole-based fluorophores. A further aspect of the present invention relates to a method of reducing and preventing aggregation of beta-amyloid peptides for Alzheimer's disease (AD) as well as of treating and/or preventing Alzheimer's disease by using carbazole-based fluorophores. | 07-31-2014 |
20140212360 | Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation - The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to methods for labeling, imaging and detecting the beta-amyloid (Aβ) peptides, oligomers, and fibrils in vitro by using carbazole-based fluorophores. A further aspect of the present invention relates to a method of reducing and preventing aggregation of beta-amyloid peptides for Alzheimer's disease (AD) as well as of treating and/or preventing Alzheimer's disease by using carbazole-based fluorophores. | 07-31-2014 |
20140200265 | USAGE OF 1,3,5,7-TETRAHYDROXY-8-ISOPRENYLXANTHONE FOR TREATING INFLAMMATION - This invention relates to the use of a natural compound from natural sources for its therapeutic uses. More particularly, it relates to a compound 1,3,5,7-tetrahydroxy-8-isoprenylxanthone (TI, FIG. | 07-17-2014 |
20140194530 | USAGE OF OBLONGIFOLIN C, A NATURAL COMPOUND FROM GARCINIA YUNNANENSIS HU, ON TREATING CANCER AS METASTASIS INHIBITOR AND AUTOPHAGIC FLUX INHIBITOR - Disclosed is a natural compound, Oblongifolin C, isolated from a natural plant comprising | 07-10-2014 |
20140194529 | USAGE OF NATURAL COMPOUND FOR TREATING INFLAMMATION AND CANCER - This invention relates to the use of a compound from natural sources for therapeutic uses. More particularly, it relates to a compound, Garcimultiflorone E, naturally occurring in the plant of | 07-10-2014 |
20140194528 | USAGE OF SODIUM HOUTTUYFONATE ON INHIBITING IDIOPATHIC PULMONARY FIBROSIS AND BLEOMYCIN INDUCED PULMONARY FIBROSIS - The present invention relates to a synthetic compound and its therapeutic uses. More particularly, it relates to a compound, Sodium Houttuyfonate, that is an addition compound of sodium bisulfite and houttuynin, and its biological activity of inhibiting idiopathic pulmonary fibrosis and bleomycin induced pulmonary fibrosis | 07-10-2014 |
20140194499 | Polyprenylated Benzoylphloroglucinols With Anticancer Activity - Two novel polyprenylated benzoylphloroglucinol derivatives, garciesculentones A and C, are disclosed in the present invention. Garciesculentones A and C exhibit cytotoxicity and/or antimigration effect against various cancer cell lines. The experimental results of the present invention suggest that Garciesculentones A and C are useful for developing into anticancer drugs. | 07-10-2014 |
20140194498 | POLYISOPRENYLATED TETRACYCLIC XANTHONE WITH ANTICANCER ACTIVITY - A novel polyisoprenylated tetracyclic xanthone, named garciesculentone B, isolated from | 07-10-2014 |
20140187801 | ASYMETRIC SYNTHESIS OF NORCANTHARIDIN ANALOUGUS BY ALKYNYLATION OF OXABENZONORBORNADIENES AND THEIR ANTICANCER ACTIVITIES - The present invention relates to a type of norcantharidin analogues and a method to synthesis such norcantharidin analogues by transition metal-catalyzed alkynylation of 7-oxabenzonorbornadienes. The present invention also relates to the use of such norcantharidin analogues in manufacture of a medicament for the treatment of cancer tumors. | 07-03-2014 |
20140187626 | OXANORBORNADIENE DERIVATIVES AND THEIR ANTICANCER ACTIVITIES - The present invention relates to chemical entities originated from natural sources and further synthesized for therapeutic uses. More particularly, the present invention relates to norcantharidin analogues synthesized by a transition metal-catalyzed alkynylation of oxanorbornadiene derivatives and their antitumor effects. | 07-03-2014 |
20140134698 | METHOD OF EXTRACTING NEURAL STEM CELLS USING NANOPARTICLES - A method of extracting neural stem cells from a living subject, comprising the steps of introducing magnetic nanoparticles into the subject, targeting the neural stem cells with the magnetic nanoparticles to form magnetic nanoparticle-targeted cells, isolating the magnetic nanoparticle-targeted cells, extracting the magnetic nanoparticles-targeted cells from the subject. | 05-15-2014 |
20140090023 | Method and Apparatus for Authenticating Location-based Services without Compromising Location Privacy - A method and an apparatus for authenticating location-based services without compromising location privacy, which comprises a comprehensive solution that preserves unconditional location privacy when authenticating either range queries using three authentication schemes for R-tree and grid-file index, together with two optimization techniques, or k-nearest neighbor queries using two authentication schemes for R-tree and Voronoi Diagram index. | 03-27-2014 |
20140086951 | Pharmaceutical Composition and Methods for Modulating Immune System, Preventing, Pretreating and/or Treating Cancers - This invention provides a pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from Radix Astragali, Radix Codonopsis, | 03-27-2014 |
20130344174 | Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of Preparation - The present invention discloses the utility of factions and compounds from | 12-26-2013 |
20130324580 | Anti-Cancer Agents Synthesized Based On Miliusane Compounds - The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to new anticancer agents based on miliusane compounds. The present invention also includes its preparation and application method for treating cancer. | 12-05-2013 |
20130323329 | Method Of Using Rhein For Treating Fibrotic Conditions And Tumors - The present invention relates to a method of using an anthraquinone derivative namely 9,10-Dihyro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, or known as Rhein, for treating chronic pancreatitis induced fibrosis of the pancreas. More particularly, the present invention relates to a method of using Rhein, its derivatives and/or chemical variants as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas. | 12-05-2013 |
20130310554 | Aqueous Diphase Solvent System for Preparing High-Purity Polysaccharides - The present invention provides an aqueous diphase solvent system for an one-step separation of high-purity polysaccharide from a mixture. In particular, the present invention provides method of purifying and isolating high molecular weight polysaccharides in plant with good homogeneity. | 11-21-2013 |
20130253942 | Methods and Apparatus for Smart Healthcare Decision Analytics and Support - The present invention discloses methods and apparatus for developing, analyzing, investigating, and advising healthcare and well-being related decisions. In particular, the present invention relates to the architecture of systems in either stand-alone or distributed/collaborative/pervasive settings, the components of the systems and their underlying processes and couplings, the computational techniques built into the methods, input data sources integrated into and output results produced and distributed by the systems, as well as the apparatus for carrying out the corresponding user interaction, data access and collection, data integration and processing, data-driven inferences and simulation, intelligent computations, decision analytics, and decision support to generating solutions to various healthcare analytics and decision-making problems. This invention also relates to two working illustrations of the methods and apparatus that present the embodiment illustrations of the present invention. | 09-26-2013 |
20130237556 | BERBERINE ALKALOID AS A MEDICAMENT FOR PREVENTION AND TREATMENT OF NEURAL DISEASE - The present invention is directed to method of preventing or treating neural disease or inhibiting accumulation of β-amyloid plaques in a subject by administering an effective dosage to the subject an agent (berberine) which inhibits the accumulation of β-amyloid- plaque, phospho-amyloid precursor protein (p-APP) and tau hyperphosphorylation in a mammalian brain. | 09-12-2013 |
20130226587 | Lip-password Based Speaker Verification System - A lip-based speaker verification system for identifying a speaker using a modality of lip motions; wherein an identification key of the speaker comprising one or more passwords; wherein the one or more passwords are embedded into lip motions of the speaker; wherein the speaker is verified by underlying dynamic characteristics of the lip motions; and wherein the speaker is required to match the one or more passwords embedded in the lip motions with registered information in a database. That is, in the case where the target speaker saying the wrong password or even in the case where an impostor knowing and saying the correct password, the nonconformities will be detected and the authentications/accesses will be denied. | 08-29-2013 |
20130210907 | METHOD FOR PREVENTING OR TREATING ENTEROCHROMAFFIN CELL HYPERPLASIA-RELATED DISEASES BY QUERCETIN ADMINISTRATION - The present invention provides methods and compositions for preventing or treating enterochromatffin cell hyperplasia-related diseases. The compositions comprise a therapeutic effective amount of Quercetin, glycosylated Quercetin, or mixture thereof. The methods comprises administering said composition as well as preparing said composition as a pharmaceutical formulation, | 08-15-2013 |
20130210906 | COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF FOR TREATING CANCER - The present invention provides two compounds, namely Compound A and B, as the potential anticancer drug, and a composition comprising said Compound A and/or B for treating cancer or tumor related diseases. The present invention also relates to methods of preparing the compounds from a natural source and a composition comprising the compounds, and using the same for treating cancer or tumor related diseases. | 08-15-2013 |
20130210752 | USING A NOVEL HIGH-THROUGHPUT YEAST CELL-BASED SCREENING PLATFORM TO IDENTIFY HMG-COA REDUCTASE INHIBITORS FROM NATURAL PRODUCTS AND THE USES OF SUCH INHIBITORS THEREOF - Methods of screening, identifying and isolating HMG-CoAR inhibitors are disclosed herein. In particular, said method is useful for screening natural raw products. The present invention also provides potent HMG-CoAR inhibitors for treatment and prevention of diseases and conditions associated with elevated cholesterol and/or blood lipid levels. | 08-15-2013 |
20130177775 | Highly Flexible Near-infrared Metamaterials - A novel multilayer flexible metamaterial that can work at near infrared (NIR) regime that can be fabricated on transparent PET substrate using flip chip transfer (FCT) technique. An embodiment of the present invention also provides novel NIR metamaterial device that can be transformed into various shapes by bending the PET substrate, wherein said metamaterial device is tunable via physical manipulation of its flexible substrate with no requirement to change the material composition of the substrate. The flexibility allows the novel NIR metamaterial device to bend and stretch, which can alter the device structure. Since the resonant frequency of each device is a function of the device structure, the resonant frequency can be tuned by the bend and stretch of the substrate. Another embodiment of the present invention further provides novel tunable sensors and emitters using such flexible metamaterials and devices. | 07-11-2013 |
20130160936 | Fabrication of Highly Flexible Near-infrared Metamaterials - A method and apparatus of fabrication of a multilayer flexible metamaterial can be fabricated using flip chip transfer (FCT) technique. This technique is different from other similar techniques such as metal lift off process, which fabricates the nanostructures directly onto the flexible substrate or nanometer printing technique. It is a solution-free FCT technique using double-side optical adhesive as the intermediate transfer layer and a tri-layer metamaterial nanostructures on a rigid substrate can be transferred onto adhesive first. Another embodiment of the present invention is the fabrication method and apparatus that allows the transfer of the metamaterial from a rigid substrate such as glass, quartz and metals onto a flexible substrate such as plastic or polymer film. Thus, a flexible metamaterial can be fabricated independent of the original substrate used. | 06-27-2013 |
20130025373 | Method And Apparatus For Measuring Amount Of Material Removed From Target In Pulsed Laser Ablation - A method for measuring the amount of material removed from a target in pulsed laser ablation is provided. The method includes generating a laser beam with a laser generator for ablating the target; driving the laser generator with a delay generator; acquiring the acoustic signal generated when the target is being ablated by the laser beam and generating an electrical signal accordingly with a microphone; amplifying the electrical signal generated by the microphone with a pre-amplifier; displaying an acoustic waveform indicating the intensity of the acoustic signal generated when the target is being ablated by the laser beam with a digital oscilloscope connected to the delay generator and the pre-amplifier; and deducing the amount of material removed from the target in the pulsed laser ablation according to the acoustic waveform in real time. An apparatus for performing the method is also provided. | 01-31-2013 |
20120269738 | Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation - The present invention relates to methods of detecting and monitoring aggregation of beta-amyloid peptides which are associated with neurodegenerative diseases as well as treating and/or preventing the neurodegenerative diseases by using carbazole-based fluorophores. In particular, the present invention provides methods for labeling and imaging the beta-amyloid (Aβ) peptides, oligomers, and fibrils in vitro and/or in vivo, as well as treating and/or preventing Alzheimer's disease by using the carbazole-based fluorophores of the present invention. | 10-25-2012 |
20120245190 | AUTOPHAGY INDUCING COMPOUND AND THE USES THEREOF - The present invention relates to a composition comprising compounds of formula (I-V), | 09-27-2012 |
20110317885 | Automatic and Semi-automatic Image Classification, Annotation and Tagging Through the Use of Image Acquisition Parameters and Metadata - A method for characterizing image contents automatically or semi-automatically using image acquisition parameters and metadata is presented. The method establishes probabilistic and deterministic relationships between different types of metadata and the semantic attributes and contents of images. It furnishes a mechanism that enables the automatic and semi-automatic classification, annotation, tagging, indexing, searching, identification or retrieval of images based on their contents, semantic properties and metadata characteristics. The method uses, but is not limited to, image capture metadata such as focal length, exposure time, relative aperture, flash information, ISO setting, angle of view, subject distance, timestamp, GPS information as well as other forms of metadata, including but not limited to, captions, keywords, headings, tags, comments, remarks, titles which may be automatically, semi-automatically, or manually generated. The present invention can be applied to image databases, web searching, personal search, community search, broad-based or vertical search engines for internet, intranet, extranet or other usages. | 12-29-2011 |
20100254601 | Method and device for use in converting a colour image into a grayscale image - A computerised device for converting a colour image data indicative of a plurality of colour image regions defining a two-dimensional colour image, into a grayscale image data indicative of a plurality of grayscale image regions defining a two-dimensional grayscale image, each of the colour image regions corresponding to one of the grayscale image regions, and wherein a luminance information and a two-dimensional chromatic information is associated with each of the colour image regions, wherein the device includes a processor and a memory store, said memory store being adapted to store a program executable by the processor so as to perform the following method steps:
| 10-07-2010 |
20090047336 | NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION - A new formulation of dehydrated lipid vesicles employs a vesicle preserver and permits the control of release and delivery of active pharmaceutical ingredients into the respiratory system for treatment in particular of asthma. The typical formulation provides controlled release of the active pharmaceutical ingredient from 0% to 100% from 0 to 72 hours after inhalation, changes the systemic administration to topical administration, allows prolonged therapeutic period for one administration, increased stability, with reduced dose, reduced systemic side effects, reduced toxicity. | 02-19-2009 |